Giuseppina Dognini

ORCID: 0000-0003-0325-9344
Publications
Citations
Views
---
Saved
---
About
Contact & Profiles
Research Areas
  • Lymphoma Diagnosis and Treatment
  • CNS Lymphoma Diagnosis and Treatment
  • Viral-associated cancers and disorders
  • Chronic Lymphocytic Leukemia Research
  • Colorectal Cancer Treatments and Studies
  • COVID-19 Clinical Research Studies
  • Hormonal Regulation and Hypertension
  • Blood Pressure and Hypertension Studies
  • Cancer, Lipids, and Metabolism
  • Cancer Treatment and Pharmacology
  • Vitamin D Research Studies
  • Advanced Breast Cancer Therapies
  • Vitamin C and Antioxidants Research
  • Renal cell carcinoma treatment
  • SARS-CoV-2 and COVID-19 Research
  • Ovarian cancer diagnosis and treatment
  • Health, Medicine and Society
  • Angiogenesis and VEGF in Cancer
  • Colorectal Cancer Surgical Treatments
  • Pain Management and Opioid Use
  • Cervical Cancer and HPV Research
  • Renin-Angiotensin System Studies
  • Multiple Myeloma Research and Treatments
  • Gastric Cancer Management and Outcomes
  • Reproductive tract infections research

Azienda Socio Sanitaria Territoriale di Bergamo Ovest
2016-2024

Azienda Ospedaliera Treviglio
2011-2024

Paediatric Integrated Cancer Service
2023

Hospital Universitario Infanta Leonor
2023

Azienda Ospedaliera San Gerardo
2016

Weatherford College
2011

San Raffaele University of Rome
2005-2008

International Extranodal Lymphoma Study Group
2008

Vita-Salute San Raffaele University
2006-2007

Istituti di Ricovero e Cura a Carattere Scientifico
2006-2007

Background: An association between ocular adnexal MALT lymphoma (OAL) and Chlamydia psittaci ( Cp ) infection has been proposed, recent reports suggest that doxycycline treatment causes tumor regression in patients with -related OAL. The effectiveness of -negative OAL not tested. Methods: In a prospective trial, 27 (15 newly diagnosed 12 having experienced relapse) were given 3-week course therapy. Objective response was assessed by computerized tomography scans or magnetic resonance imaging...

10.1093/jnci/djj373 article EN JNCI Journal of the National Cancer Institute 2006-10-04

Background and Objectives This study explored variations in the clinical manifestations of intravascular lymphoma (IVL) on bases association with hemophagocytosis country where diagnosis was made.Design Methods The features 50 Western patients IVL were compared those 123 diagnosed Eastern countries (87 Japan 36 other Asian countries), previously reported English literature, collected by an electronic bibliographic search.Results Hemophagocytosis absent patients, but 38 (44%) Japanese...

10.3324/haematol.10829 article EN cc-by-nc Haematologica 2007-04-01

Some case reports and a Japanese series suggest benefit from the use of rituximab in patients with intravascular large B-cell lymphoma (IVL). Rituximab efficacy was evaluated Western IVL, comparing outcome 10 treated + chemotherapy (R-CT) 20 alone (CT). There were no significant differences patients' characteristics between two subgroups. The addition associated improved complete remission rate (90% vs. 50%; P = 0.04), event-free survival (3-year: 89% 35%; 0.003) overall 38%; 0.01). In...

10.1111/j.1365-2141.2008.07338.x article EN British Journal of Haematology 2008-08-11

Ocular adnexal MALT lymphoma (OAML) is linked to Chlamydophila psittaci (Cp) infection. Viability and infectivity of Cp, demonstrated by growth in culture, has not been yet investigated these patients. We conducted a single-center prospective case-control study assess the prevalence, viability Cp 20 OAML patients 42 blood donors registered 6-month period. The presence conjunctival swabs peripheral mononuclear cells (PBMC) was assessed TETR-PCR vitro cultures. From an epidemiological point...

10.1002/ijc.23596 article EN International Journal of Cancer 2008-06-04

The prevalence and the clinical impact of gastric Helicobacter pylori (Hp) infection, as well its possible correlation with Chlamydia psittaci (Cps) infection lymphoma regression rate produced by Hp eradicating antibiotic therapy were investigated in patients MALT-type ocular adnexa (OAL).During staging, presence was assessed gastroscopy multiple biopsies 31 OAL patients. Immediately after, Hp-positive treated therapy, alone or associated other therapies.Gastric detected 10 (32%) patients;...

10.1002/hon.768 article EN Hematological Oncology 2005-12-30

Ocular adnexal marginal zone B-cell lymphoma (OAMZL) has been associated with Chlamydophila psittaci, an infection that may be transmitted by carrier animals. However, it is still unclear whether exposure to animals affects the risk of OAMZL in comparison other histotypes. We therefore investigated role professional and/or domestic exposures occurrence OAMZL, as compared types lymphoma.A hospital-based case-control study was carried out on 43 consecutive patients (cases) and 87 nodal...

10.1038/bjc.2012.2 article EN cc-by-nc-sa British Journal of Cancer 2012-01-24

We report the first case of diffuse large B-cell lymphoma (DLBCL) stomach displaying CD20-negative relapse after rituximab-containing treatment and re-appearance CD20 expression at second failure. The loss in lymphomas relapsing rituximab is a well-known phenomenon, but its actual impact DLBCL difficult to estimate. This paradigmatic suggests that CD20-expression reappearance purging CD20-positive clones with might be an underestimated occurrence lymphomas. Accordingly, every relapse,...

10.3324/haematol.10255 article EN cc-by-nc Haematologica 2007-01-01

<i>Objectives:</i> As single agents, irinotecan and oxaliplatin are active in colorectal cancer after fluorouracil (FU)-containing regimen failure. Their synergistic activity non-overlapping toxicity profile well documented, but more data needed to explore their exact sequence. The aim of this study was evaluate the tolerability followed by patients with FU-resistant cancer. <i>Methods:</i> FU resistance defined as disease progression during or within 6 months...

10.1159/000077439 article EN Oncology 2004-01-01

Aims and background As raltitrexed oxaliplatin (L-OHP) are both effective in the treatment of colorectal cancer but have different mechanisms action, we studied antitumoral activity safety their combined use patients with advanced cancer. Methods A 15-min intravenous infusion (2.5 mg/m 2 ) a 180-min (100 were administered on day 1 every three weeks for maximum six cycles. Results The study involved 51 (27 males 24 females) median age 65 years (range, 43-78); 28 aged ≥65 years. primary tumor...

10.1177/030089160409000205 article EN Tumori Journal 2004-03-01

ABSTRACT We report the case of a 69-year-old man with acute pulmonary echinococcosis. A computed tomographic scan thorax revealed presence multiple nodules in both lungs, and laboratory tests showed eosinophilia antibodies against Echinococcus granulosus . Therapy albendazole led to resolution normalization white cell count. To our knowledge this is first described echinococcosis, as diagnosis disease usually delayed chronic phases. Therefore, finding unexplained eosinophilia, especially...

10.1128/jcm.38.12.4679-4680.2000 article EN Journal of Clinical Microbiology 2000-12-01

AbstractThis study reports the tolerability and feasibility of capecitabine, an oral fluoropyrimidine, chemoradiation as postoperative treatment. Stage II-III rectal cancer patients received 2 cycles bolus 5-FU (425 mg/m2) leucovorin (LV) (20 on days 1-5 q3w followed by capecitabine (800 mg/m2 bid) continuously during pelvic radiotherapy (total 50.4 Gy). Two additional 5-FU/LV were finally administered.Forty-one radically resected (median age: 61 years) enrolled. All evaluable for safety....

10.1179/joc.2006.18.1.85 article EN Journal of Chemotherapy 2006-02-01
Coming Soon ...